{"id":8980,"date":"2015-12-10T11:45:03","date_gmt":"2015-12-10T02:45:03","guid":{"rendered":"http:\/\/cell.brc.riken.jp\/en\/?page_id=8980"},"modified":"2015-12-17T11:54:44","modified_gmt":"2015-12-17T02:54:44","slug":"mn20151211","status":"publish","type":"page","link":"http:\/\/cell.brc.riken.jp\/en\/mail_news\/mn20151211","title":{"rendered":"RIKEN BRC Cell Bank MAILNEWS  2015.12.11"},"content":{"rendered":"<pre>\r\n*******************************************\r\nRIKEN BioResource Center Cell Bank\r\n   MAILNEWS 2015.12.11\r\n<blockquote class=\"wp-embedded-content\" data-secret=\"cttzjbr6Ww\"><a href=\"http:\/\/cell.brc.riken.jp\/en\/\">News<\/a><\/blockquote><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;News&#8221; &#8212; Cell Engineering Division -CELL BANK-\" src=\"http:\/\/cell.brc.riken.jp\/en\/embed#?secret=cttzjbr6Ww\" data-secret=\"cttzjbr6Ww\" width=\"600\" height=\"338\"  marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\r\n*******************************************\r\n\r\nRIKEN BioResource Center Cell Bank is announcing our first e-mail \r\nnewsletter. \r\n\r\n====Contents========================\r\n- About RIKEN BRC Cell Bank\r\n- Newly cataloged cell lines (2015.12)\r\n- Holiday Closing Announcement\r\n===================================\r\nWe hope you find the contents of this message of interest.\r\nHowever, if you would prefer to unsubscribe from future e-mails, \r\nplease send an e-mail to  <a href=\"mailto:&#99;&#101;l&#108;b&#x61;nk.b&#x72;c&#x40;r&#105;ken&#46;&#x6a;&#112;\">cellbank.brc<img loading=\"lazy\" decoding=\"async\" title=\"\" alt=\"\" src=\"\/ja\/wp-content\/uploads\/images\/at.png\" width=\"13\" height=\"13\" \/>riken.jp<\/a>.\r\n\r\n===================================\r\n- About RIKEN BRC Cell Bank\r\n===================================\r\n\r\nThe Cell Engineering Division of RIKEN BioResource Center is a \r\nnot-for-profit public \"cell bank\" that accepts donations and \r\ndeposits of human and animal cell materials developed by the life \r\nscience research community. \r\nWe examine, standardize, amplify, preserve, and provide cell \r\nmaterials to scientists around the world. \r\nThe major cell materials used around the world have been cultured \r\ncell lines, i.e., immortalized cells. \r\nIn fact, the majority of human cell materials are cancer cell lines. \r\nThere is no doubt that the demand for these cell lines will never \r\ncease in the field of biology. \r\nIn addition, stem cell lines such as embryonic stem (ES) cells and \r\ninduced pluripotent stem (iPS) cells are of great value in current \r\nbiology and medical sciences. \r\nIn particular, disease-specific (patient-specific) iPS cells are \r\nvery useful for researches of disease and drug discovery. \r\nIn addition, the CRISPR\/Cas9 technology, a recently established \r\nnew genome-editing technology, is rapidly spreading in many fields \r\nof life sciences. We will collect and provide all kinds of such \r\nuseful cell materials.\r\nOur work is accredited by ISO9001.\r\n\r\n  Yukio NAKAMURA, M.D., Ph.D.\r\n\r\n===================================\r\n- Newly cataloged cell lines (2015.12)\r\n===================================\r\n<a href=\"\/en\/new_resource\">http:\/\/cell.brc.riken.jp\/en\/new_resource<\/a>\r\n\r\n## Human iPS cells (HPS)  19 cell lines ##\r\n\r\n<strong>HPS0059  <\/strong>\r\nDisease specific iPS cell line derived from a patient : Amyotrophic \r\nlateral sclerosis.\r\n<strong>HPS0060 <\/strong> \r\nDisease specific iPS cell line derived from a patient : Dementia of \r\nAlzheimer's type.  \r\n<strong>HPS0136  <\/strong>\r\nDisease specific iPS cell line derived from a patient : Amyotrophic \r\nlateral sclerosis, Sporadic type (pseudo-polyneuritic, w\/o UMN). \r\nHPS0134 was derived from the same patient. iPS cells were created \r\nusing the Sendai virus vector.\r\n<strong>HPS0148  <\/strong>\r\nDisease specific iPS cell line derived from a patient : Amyotrophic \r\nlateral sclerosis, Sporadic type (bulbar, with UMN). HPS0146 and\r\nHPS0147 were derived from the same patient. iPS cells were created \r\nusing the Sendai virus vector.\r\n<strong>HPS0180  <\/strong>\r\nDisease specific iPS cell line derived from a patient :Progressive \r\nsystemic sclerosis (PSS), HPS0178 was derived from the same patient. \r\nSystematic Sclerosis (SSc). iPS cells were created using the Sendai \r\nvirus vector. \r\n<strong>HPS0185  <\/strong>\r\nDisease specific iPS cell line derived from a patient : Progressive \r\nsystemic sclerosis (PSS), Systematic Sclerosis (SSc). HPS0184 was \r\nderived from the same patient. iPS cells were created using the \r\nSendai virus vector. \r\n<strong>HPS0211 <\/strong> \r\nDisease specific iPS cell line derived from a patient : Pulmonary \r\nhypertension. HPS0209 was derived from the same patient. iPS cells \r\nwere created using the Sendai virus vector. \r\n<strong>HPS0226  <\/strong>\r\nDisease specific iPS cell line derived from a patient : Amyloid \r\nneuropathy, Familial type. HPS0224 was derived from the same \r\npatient. iPS cells were created using the Sendai virus vector. \r\n<strong>HPS0228<\/strong>  \r\nDisease specific iPS cell line derived from a patient : Amyloid \r\nneuropathy, Familial type. HPS0227 wasderived from the same \r\npatient. iPS cells were created using the Sendai virus vector. \r\n<strong>HPS0234  <\/strong>\r\nDisease specific iPS cell line derived from a patient : Muscular \r\ndystrophy, Becker type. HPS0233 was derived from the same patient.\r\niPS cells were created using the Sendai virus vector. \r\n<strong>HPS0247 <\/strong> \r\nDisease specific iPS cell line derived from a patient : Amyotrophic \r\nlateral sclerosis. \r\n<strong>HPS0248 <\/strong> \r\nDisease specific iPS cell line derived from a patient : Amyotrophic \r\nlateral sclerosis. \r\n<strong>HPS0249 <\/strong> \r\nDisease specific iPS cell line derived from a patient : Amyotrophic \r\nlateral sclerosis. \r\n<strong>HPS0254  <\/strong>\r\nDisease specific iPS cell line derived from a patient : Alzheimer \r\ndisease. \r\n<strong>HPS0255 <\/strong> \r\nDisease specific iPS cell line derived from a patient : Alzheimer \r\ndisease.\r\n<strong>HPS0256 <\/strong>\r\nDisease specific iPS cell line derived from a patient : Alzheimer \r\ndisease. \r\n<strong>HPS0263 <\/strong> \r\nDisease specific iPS cell line derived from a patient : Huntington's \r\ndisease. \r\n<strong>HPS0266 <\/strong> \r\nDisease specific iPS cell line derived from a patient : Adenosine \r\ndeaminase deficiency (ADA). HPS0265 was derived from the same patient. \r\n<strong>HPS0312  <\/strong>\r\nDisease specific iPS cell line derived from a patient : Muscular \r\ndystrophy, Duchenne type. \r\n\r\n## Mouse ES cells (AES)  4 cell lines ##\r\n\r\n<strong>AES1233 26v-009<\/strong>\r\nThe Gene-trap Mouse ES cell (V6.4) clone. The NAISTrapdata bese :\r\nNAISTrap_26v-009.\r\n<strong>AES1421 37v-42<\/strong>\r\nThe Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese :\r\nNAISTrap_37v-42.\r\n<strong>AES1519 38v-29  <\/strong>\r\nThe Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese :\r\nNAISTrap_38v-29.\r\n<strong>AES2228 TPM2-187 <\/strong> \r\nThe Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_012060 \r\n\r\n## General cell lines (RCB)  7 cell lines ##\r\n\r\n<strong>RCB3576 Aska-SS <\/strong> \r\nHuman cell line derived from synovial sarcoma. \r\n<strong>RCB3577 Yamato-SS  <\/strong>\r\nHuman cell line derived from synovial sarcoma.\r\n<strong>RCB4452 FL-YB  <\/strong>\r\nMouse follicular dendritic cell line.\r\n<strong>RCB4593 CALM WT MEF  <\/strong>\r\nCALM non-deficient MEF cells. Transformed with SV40 large T \r\nantigen gene.   \r\n<strong>RCB4594 CALM KO MEF  <\/strong>\r\nCALM deficient MEF cells. Transformed with SV40 large T antigen gene. \r\n<strong>RCB4623 Ba\/ER  <\/strong>\r\nBa\/ER was created by stable transfection of murine pro-B Ba\/F3 cells \r\nwith a murine erythropoietin receptor gene. Ba\/ER proliferates \r\ndependent on erythropoietin or interleukin-3.\r\n<strong>RCB4627 KUP5  <\/strong>\r\nAn immortalized mouse Kupffer cell line established from C57BL\/6 \r\nstrain. The Kupffer cells were proliferated in the Mixed primary \r\nculture of C57BL\/6 adult mouse liver cells, then infected with a\r\nreplication-deficient retroviral vector containing the human c-myc \r\noncogene and neomycin resistance gene, isolated and selected with \r\nG418 (cloned by a limited dilution).\r\n\r\n===================================\r\n- Holiday Closing Announcement\r\n===================================\r\n\r\nRIKEN BRC will be closed from December 29, 2015 through \r\nJanuary 3, 2016 due to New Year's holidays.\r\nWe will resume normal business from January 4, 2016.\r\nWe wish you a wonderful holiday season, and all the best for \r\nthe New Year !\r\n\r\n===================================\r\n*If you have any questions or comments, please send an e-mail to \r\n<a href=\"mailto:&#99;&#101;l&#108;b&#x61;nk.b&#x72;c&#x40;r&#105;ken&#46;&#x6a;&#112;\">cellbank.brc<img loading=\"lazy\" decoding=\"async\" title=\"\" alt=\"\" src=\"\/ja\/wp-content\/uploads\/images\/at.png\" width=\"13\" height=\"13\" \/>riken.jp<\/a>.\r\n*Content is subject to change without notice.\r\n*All Rights Reserved.\r\n_________________________________________\r\nRIKEN BioResource Center Cell Bank\r\n3-1-1 Koyadai, Tsukuba-shi\r\nIbaraki, 305-0074 Japan\r\n<a href=\"mailto:&#99;&#101;l&#108;b&#x61;nk.b&#x72;c&#x40;r&#105;ken&#46;&#x6a;&#112;\">cellbank.brc<img loading=\"lazy\" decoding=\"async\" title=\"\" alt=\"\" src=\"\/ja\/wp-content\/uploads\/images\/at.png\" width=\"13\" height=\"13\" \/>riken.jp<\/a>.\r\n<blockquote class=\"wp-embedded-content\" data-secret=\"cttzjbr6Ww\"><a href=\"http:\/\/cell.brc.riken.jp\/en\/\">News<\/a><\/blockquote><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;News&#8221; &#8212; Cell Engineering Division -CELL BANK-\" src=\"http:\/\/cell.brc.riken.jp\/en\/embed#?secret=cttzjbr6Ww\" data-secret=\"cttzjbr6Ww\" width=\"600\" height=\"338\"  marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\r\n_________________________________________\r\n2015.12.11.\r\n<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>******************************************* RIKEN BioResource Center Cell Bank MAILNEWS 2015.12.11 News ******************************************* RIKEN BioResource Center Cell Bank is announcing our first e-mail newsletter. ====Contents======================== &#8211; About RIKEN BRC Cell Bank &#8211; Newly cataloged cell lines (2015.12) &#8211; Holiday Closing Announcement =================================== We hope you find the contents of this message of interest. However, if you would prefer to unsubscribe from future e-mails, please send an e-mail to cellbank.brcriken.jp. =================================== &#8211; About RIKEN BRC Cell Bank =================================== The Cell Engineering Division of RIKEN BioResource Center is a not-for-profit public &#8220;cell bank&#8221; that accepts donations and deposits of human and animal cell materials developed by the life science research community. We examine, standardize, amplify, preserve, and provide cell materials to scientists around the world. The major cell materials used around the world have been cultured cell lines, i.e., immortalized cells. In fact, the majority of human cell materials are cancer cell lines. There is no doubt that the demand for these cell lines will never cease in the field of biology. In addition, stem cell lines such as embryonic stem (ES) cells and induced pluripotent stem (iPS) cells are of great value in current biology and medical sciences. In particular, disease-specific (patient-specific) iPS cells [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":8973,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-8980","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/8980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=8980"}],"version-history":[{"count":3,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/8980\/revisions"}],"predecessor-version":[{"id":8991,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/8980\/revisions\/8991"}],"up":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/8973"}],"wp:attachment":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=8980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}